US5387680A
Expired / Lapsed
US
⏱️ 0.0 years remaining
C-22 ring stabilized rapamycin derivatives
Assignee: Wyeth LLC
•
Filing: 1993-08-10
•
Granted: 1995-02-07
•
Expires: 2013-08-10
Abstract
Abstract This invention provides C-22 substituted rapamycin derivatives of the following formulas: ##STR1## and pharmaceutically acceptable salts thereof which are useful for inducing immunosuppression and treating transplantation rejection, host vs. graft disease, autoimmune diseases, diseases of inflammation, solid tumors, fungal infections, adult T-cell leukemia/lymphomas and hyperproliferative vascular disorders.
Inventors
- 👤 Frances C. Nelson
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 12:59
CPC Classifications
C; C07; C07D; C07D498/00; C07D498/12; C07D498/18; A; A61; A61P; A61P29/00; A61P37/00; A61P37/02; A61P37/06
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
89 words
A compound of the formula: ##STR33## wherein R 1 is C 1 -C 6 lower alkyl, C 1 -C 6 lower acyl, C 1 -C 6 alkylthio, C 6 -C 10 aryl, C 7 -C 16 arylalkyl, C 6 -C 10 arylthio, C 7 -C 16 arylalkylthio, cyano, C 1 -C 6 perfluorinated lower alkyl, or ##STR34## wherein R is a chain of 1-5 carbon atoms; and R 2 , R 3 and R 4 are each independently hydrogen or SiEt 3 ; or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim
89 words
A compound of the formula: ##STR33## wherein R 1 is C 1 -C 6 lower alkyl, C 1 -C 6 lower acyl, C 1 -C 6 alkylthio, C 6 -C 10 aryl, C 7 -C 16 arylalkyl, C 6 -C 10 arylthio, C 7 -C 16 arylalkylthio, cyano, C 1 -C 6 perfluorinated lower alkyl, or ##STR34## wherein R is a chain of 1-5 carbon atoms; and R 2 , R 3 and R 4 are each independently hydrogen or SiEt 3 ; or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim
14 words
A compound of claim 1 which is C-22-methyl-rapamycin or a pharmaceutically acceptable salt thereof.
Claim 4
Dependent Claim
14 words
A compound of claim 1 which is C-22-ethyl-rapamycin or a pharmaceutically acceptable salt thereof.
Claim 5
Dependent Claim
14 words
A compound of claim 1 which is C-22-methyl-C-27-hydroxy-rapamycin or a pharmaceutically acceptable salt thereof.
Claim 6
Dependent Claim
14 words
A compound of claim 1 which is C-22-ethyl-C-27-hydroxy-rapamycin or a pharmaceutically acceptable salt thereof.
Claim 7
Dependent Claim
1224 words
A compound of the formula: ##STR35## wherein R 1 is C 1 -C 6 lower alkyl, C 1 -C 6 alkylthio, C 6 -C 10 aryl, C 7 -C 16 arylalkyl, C 6 -C 10 arylthio, C 7 -C 16 arylalkylthio, cyano, C 1 -C 6 perfluorinated lower alkyl, or ##STR36## wherein R is a chain of 1-5 carbon atoms; and R 2 , R 3 , and R 4 are each independently: a.) hydrogen; or b.) SiEt 3 ; or ##STR37## wherein R 5 is hydrogen, alkyl of 1-6 carbon atoms, aminoalkyl of 1-4 carbon atoms, aralkyl of 7-10 carbon atoms, --(CH 2 ) q CO 2 R 8 , --(CH 2 ) r NR 9 CO 2 R 10 , carbamylalkyl of 2-3 carbon atoms, hydroxyalkyl of 1-4 carbon atoms, guanylalkyl of 2-4 carbon atoms, mercaptoalkyl of 1-4 carbon atoms, alkylthioalkyl of 2-6 carbon atoms, indolylmethyl, hydroxyphenylmethyl, imidazolylmethyl or phenyl which is optionally mono-, di- or tri-substituted with a substituent selected form alkyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, hydroxy, cyano, halo, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, amino, or --CO 2 H; R 6 and R 9 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, or aralkyl of 7-10 carbon atoms; R 7 , R 8 , and R 10 are each, independently, alkyl of 1-6 carbon atoms, aralkyl of 7-10 carbon atoms, fluorenylmethyl, or phenyl which is optionally mono-, di-, or tri-substituted with a substituent selected from alkyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, hydroxy, cyano, halo, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, amino, or --CO 2 H; m is 0-4; n is 0-4; p is 1-2; q is 0-4; r is 0-4; wherein R 5 , R 6 , m, and n are independent in each of the ##STR38## subunits when p=2; or d.) --CONH(CR 11 R 12 ) n --X wherein R 11 and R 12 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, aralkyl of 7-10 carbon atoms, cycloalkyl of 3-8 carbon atoms, halogen, or trifluoromethyl; X is hydrogen, lower alkyl of 1-6 carbon atoms, cycloalkyl of 3-8 carbon atoms, trifluoromethyl, nitro, alkoxy of 1-6 carbon atoms, carboalkoxy of 2-7 carbon atoms, aralkyl of 7-10 carbon atoms, halo, dialkylamino of 1-6 carbon atoms per alkyl group, thioalkyl of 1-6 carbon atoms, or Y; Y is a phenyl group which may be optionally mono-, di-, or tri-substituted with a group selected from alkyl of 1-6 carbon atoms, aralkyl of 7-10 carbon atoms, alkoxy of 1-6 carbon atoms, cyano, halo, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, dialkylamino of 1-6 carbon atoms per alkyl group, alkylthio of 1-6 carbon atoms, --SO 3 H, --PO 3 H, or --CO 2 H; n=0-5; with the proviso that R 2 , R 3 and R 4 are not all hydrogen and when n=0, X is lower alkyl of 1-6 carbon atoms, cycloalkyl of 3-8 carbon atoms, aralkyl of 7-10 carbon atoms, or Y; or ##STR39## wherein R 13 is a mono-, di-, poly-, or per-fluorinated alkyl group of 1-10 carbon atoms, with the proviso that R 2 , R 3 and R 4 are not all hydrogen, alkyl of 1-10 carbon atoms, arylalkyl of 7-10 carbon atoms, or aryl wherein the aryl group may be optionally mono-, di-, or tri-substituted with a group selected from alkyl of 1-6 carbon atoms, arylalkyl of 7-10 carbon atoms, alkoxy of 1-6 carbon atoms, cyano, halo, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, amino, dialkylamino of 1-6 carbon atoms per alkyl group, alkylthio of 1-6 carbon atoms, --SO 3 H, --PO 3 H, and --CO 2 H; or ##STR40## wherein X is --(CH 2 ) m -- or --Ar--; R 14 and R 15 are each, independently, hydrogen, alkyl of 1-12 carbon atoms, --(CH 2 ) n --Ar, --(CH 2 ) p --NR 16 R 17 , or --(CH 2 ) p --N+R 16 R 17 R 18 Y--; R 16 and R 17 are each, independently, hydrogen, alkyl of 1-12 carbon atoms, or --(CH 2 ) n --Ar; Ar is an optionally mono- or di-substituted group selected from ##STR41## in which the optional substituents are selected from the group consisting of alkyl of 1-6 carbon atoms, aralkyl of 7-10 carbon atoms, alkoxy of 1-6 carbon atoms, cyano, halo, nitro, carbalkoxy of 2-7 carbon atoms, or perfluoroalkyl of 1-6 carbon atoms; R 8 is alkyl of 1-6 carbon atoms; Y is a halide, sulfate, phosphate, or p-toluenesulfonate anion; m=1-6; n=1-6; p=1-6; or g.) --CONHSO 2 --Ar wherein Ar is phenyl, naphthyl, pyridyl, quinolyl, isoquinolyl, quinoxalyl, thienyl, thionaphthyl, furyl, benzofuryl, benzodioxyl, benxoxazolyl, benzoisoxazolyl, or benzodioxolyl; wherein the Ar group may be optionally mono-, di-, or tri-substituted with a group selected from alkyl of 1-6 carbon atoms, arylalkyl of 7-10 carbon atoms, alkoxy of 1-6 carbon atoms, cyano, halo, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, amino, dialkylamino of 1-6 carbon atoms per alkyl group, alkylthio of 1-6 carbon atoms, --SO 3 H, --PO 3 H, or --CO 2 H; with the proviso that R 2 , R 3 and R 4 are not all hydrogen; or a pharmaceutically acceptable salt thereof when the Ar group contains a basic nitrogen or when the Ar group is substituted by dialkylamino of 1-6 carbon atoms per alkyl group, --SO 3 H, --PO 3 H, or --CO 2 H; h) --SO 2 R 19 wherein R 19 is alkyl, alkenyl, or alkynyl containing 1 to 6 carbon atoms; or an aromatic moiety selected from the group consisting of phenyl and naphthyl or a heterocyclic moiety selected from the group consisting of thiophenyl and quinolinyl or NHCO 2 R 20 wherein R 20 is lower alkyl containing 1 to 6 carbon atoms; or ##STR42## wherein R 21 and R 22 are each, independently, hydrogen or alkyl of 1-3 carbon atoms or, if R 21 and R 22 are alkyl of 1-3 carbon atoms, R 21 and R 22 together with the nitrogen to which they are attached form a saturated heterocyclic ring having 4-5 carbon atoms; and m=1-3: or ##STR43## wherein R 24 is hydrogen, alkyl of 1-6 carbon atoms, arylalkyl of 7-10 carbon atoms, (CH 2 ) s NR 25 R 26 , aminoalkyl of 1-4 carbon atoms, hydroxyalkyl of 1-4 carbon atoms, guanylalkyl of 2-4 carbon atoms, mercaptoalkyl of 1-4 carbon atoms, alkylthioalkyl of 2-6 carbon atoms, indolmethyl, hydroxyphenylmethyl, imidazolylmethyl, or phenyl which is optionally mono-, di-, or tri-substituted with a substituent selected from alkyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, hydroxy, cyano, halo, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, amino, or --CO 2 H; R 25 is hydrogen, alkyl of 1-6 carbon atoms, or aralkyl of 7-10 carbon atoms; R 23 and R 26 are each independently hydrogen, formyl, alkanoyl of 2-7 carbon atoms, arylalkanoyl of 8-11 carbon atoms, aryloyl, or CO 2 R 27 ; R 27 is alkyl of 1-6 carbon atoms, arylalkyl of 7-10 carbon atoms, allyl, fluorenylmethyl, or phenyl which is optionally mono-, di-, or tri-substituted with a substituent selected from alkyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, hydroxy, cyano, halo, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, amino or --CO 2 H; m is 0-4; n is 0-4; p is 0-1; q is 0-4; r is 0-4; and s is 0-4 or a pharmaceutically acceptable salt thereof.
Claim 8
Dependent Claim
1224 words
A compound of the formula: ##STR35## wherein R 1 is C 1 -C 6 lower alkyl, C 1 -C 6 alkylthio, C 6 -C 10 aryl, C 7 -C 16 arylalkyl, C 6 -C 10 arylthio, C 7 -C 16 arylalkylthio, cyano, C 1 -C 6 perfluorinated lower alkyl, or ##STR36## wherein R is a chain of 1-5 carbon atoms; and R 2 , R 3 , and R 4 are each independently: a.) hydrogen; or b.) SiEt 3 ; or ##STR37## wherein R 5 is hydrogen, alkyl of 1-6 carbon atoms, aminoalkyl of 1-4 carbon atoms, aralkyl of 7-10 carbon atoms, --(CH 2 ) q CO 2 R 8 , --(CH 2 ) r NR 9 CO 2 R 10 , carbamylalkyl of 2-3 carbon atoms, hydroxyalkyl of 1-4 carbon atoms, guanylalkyl of 2-4 carbon atoms, mercaptoalkyl of 1-4 carbon atoms, alkylthioalkyl of 2-6 carbon atoms, indolylmethyl, hydroxyphenylmethyl, imidazolylmethyl or phenyl which is optionally mono-, di- or tri-substituted with a substituent selected form alkyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, hydroxy, cyano, halo, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, amino, or --CO 2 H; R 6 and R 9 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, or aralkyl of 7-10 carbon atoms; R 7 , R 8 , and R 10 are each, independently, alkyl of 1-6 carbon atoms, aralkyl of 7-10 carbon atoms, fluorenylmethyl, or phenyl which is optionally mono-, di-, or tri-substituted with a substituent selected from alkyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, hydroxy, cyano, halo, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, amino, or --CO 2 H; m is 0-4; n is 0-4; p is 1-2; q is 0-4; r is 0-4; wherein R 5 , R 6 , m, and n are independent in each of the ##STR38## subunits when p=2; or d.) --CONH(CR 11 R 12 ) n --X wherein R 11 and R 12 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, aralkyl of 7-10 carbon atoms, cycloalkyl of 3-8 carbon atoms, halogen, or trifluoromethyl; X is hydrogen, lower alkyl of 1-6 carbon atoms, cycloalkyl of 3-8 carbon atoms, trifluoromethyl, nitro, alkoxy of 1-6 carbon atoms, carboalkoxy of 2-7 carbon atoms, aralkyl of 7-10 carbon atoms, halo, dialkylamino of 1-6 carbon atoms per alkyl group, thioalkyl of 1-6 carbon atoms, or Y; Y is a phenyl group which may be optionally mono-, di-, or tri-substituted with a group selected from alkyl of 1-6 carbon atoms, aralkyl of 7-10 carbon atoms, alkoxy of 1-6 carbon atoms, cyano, halo, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, dialkylamino of 1-6 carbon atoms per alkyl group, alkylthio of 1-6 carbon atoms, --SO 3 H, --PO 3 H, or --CO 2 H; n=0-5; with the proviso that R 2 , R 3 and R 4 are not all hydrogen and when n=0, X is lower alkyl of 1-6 carbon atoms, cycloalkyl of 3-8 carbon atoms, aralkyl of 7-10 carbon atoms, or Y; or ##STR39## wherein R 13 is a mono-, di-, poly-, or per-fluorinated alkyl group of 1-10 carbon atoms, with the proviso that R 2 , R 3 and R 4 are not all hydrogen, alkyl of 1-10 carbon atoms, arylalkyl of 7-10 carbon atoms, or aryl wherein the aryl group may be optionally mono-, di-, or tri-substituted with a group selected from alkyl of 1-6 carbon atoms, arylalkyl of 7-10 carbon atoms, alkoxy of 1-6 carbon atoms, cyano, halo, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, amino, dialkylamino of 1-6 carbon atoms per alkyl group, alkylthio of 1-6 carbon atoms, --SO 3 H, --PO 3 H, and --CO 2 H; or ##STR40## wherein X is --(CH 2 ) m -- or --Ar--; R 14 and R 15 are each, independently, hydrogen, alkyl of 1-12 carbon atoms, --(CH 2 ) n --Ar, --(CH 2 ) p --NR 16 R 17 , or --(CH 2 ) p --N+R 16 R 17 R 18 Y--; R 16 and R 17 are each, independently, hydrogen, alkyl of 1-12 carbon atoms, or --(CH 2 ) n --Ar; Ar is an optionally mono- or di-substituted group selected from ##STR41## in which the optional substituents are selected from the group consisting of alkyl of 1-6 carbon atoms, aralkyl of 7-10 carbon atoms, alkoxy of 1-6 carbon atoms, cyano, halo, nitro, carbalkoxy of 2-7 carbon atoms, or perfluoroalkyl of 1-6 carbon atoms; R 8 is alkyl of 1-6 carbon atoms; Y is a halide, sulfate, phosphate, or p-toluenesulfonate anion; m=1-6; n=1-6; p=1-6; or g.) --CONHSO 2 --Ar wherein Ar is phenyl, naphthyl, pyridyl, quinolyl, isoquinolyl, quinoxalyl, thienyl, thionaphthyl, furyl, benzofuryl, benzodioxyl, benxoxazolyl, benzoisoxazolyl, or benzodioxolyl; wherein the Ar group may be optionally mono-, di-, or tri-substituted with a group selected from alkyl of 1-6 carbon atoms, arylalkyl of 7-10 carbon atoms, alkoxy of 1-6 carbon atoms, cyano, halo, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, amino, dialkylamino of 1-6 carbon atoms per alkyl group, alkylthio of 1-6 carbon atoms, --SO 3 H, --PO 3 H, or --CO 2 H; with the proviso that R 2 , R 3 and R 4 are not all hydrogen; or a pharmaceutically acceptable salt thereof when the Ar group contains a basic nitrogen or when the Ar group is substituted by dialkylamino of 1-6 carbon atoms per alkyl group, --SO 3 H, --PO 3 H, or --CO 2 H; h) --SO 2 R 19 wherein R 19 is alkyl, alkenyl, or alkynyl containing 1 to 6 carbon atoms; or an aromatic moiety selected from the group consisting of phenyl and naphthyl or a heterocyclic moiety selected from the group consisting of thiophenyl and quinolinyl or NHCO 2 R 20 wherein R 20 is lower alkyl containing 1 to 6 carbon atoms; or ##STR42## wherein R 21 and R 22 are each, independently, hydrogen or alkyl of 1-3 carbon atoms or, if R 21 and R 22 are alkyl of 1-3 carbon atoms, R 21 and R 22 together with the nitrogen to which they are attached form a saturated heterocyclic ring having 4-5 carbon atoms; and m=1-3: or ##STR43## wherein R 24 is hydrogen, alkyl of 1-6 carbon atoms, arylalkyl of 7-10 carbon atoms, (CH 2 ) s NR 25 R 26 , aminoalkyl of 1-4 carbon atoms, hydroxyalkyl of 1-4 carbon atoms, guanylalkyl of 2-4 carbon atoms, mercaptoalkyl of 1-4 carbon atoms, alkylthioalkyl of 2-6 carbon atoms, indolmethyl, hydroxyphenylmethyl, imidazolylmethyl, or phenyl which is optionally mono-, di-, or tri-substituted with a substituent selected from alkyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, hydroxy, cyano, halo, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, amino, or --CO 2 H; R 25 is hydrogen, alkyl of 1-6 carbon atoms, or aralkyl of 7-10 carbon atoms; R 23 and R 26 are each independently hydrogen, formyl, alkanoyl of 2-7 carbon atoms, arylalkanoyl of 8-11 carbon atoms, aryloyl, or CO 2 R 27 ; R 27 is alkyl of 1-6 carbon atoms, arylalkyl of 7-10 carbon atoms, allyl, fluorenylmethyl, or phenyl which is optionally mono-, di-, or tri-substituted with a substituent selected from alkyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, hydroxy, cyano, halo, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, amino or --CO 2 H; m is 0-4; n is 0-4; p is 0-1; q is 0-4; r is 0-4; and s is 0-4 or a pharmaceutically acceptable salt thereof.
Claim 9
Dependent Claim
9 words
A compound of claim 6 which is C-22-methyl-42-dimethylglycine rapamycin.
References Cited (Backward Citations)
US3929992A
Cited
US3993749A
Cited
US4885171A
Cited
US4316885A
Cited
US4401653A
Cited
US4650803A
Cited
US5100899A
Cited
US5130307A
Cited
US5078999A
Cited
US5080899A
Cited
US5120842A
Cited
US5120842B1
Cited
EP0507555A1
Cited
US5100883A
Cited
US5118678A
Cited
US5091389A
Cited
US5102876A
Cited
US5118677A
Cited
EP0525960A1
Cited
US5138051A
Cited
US5169851A
Cited
US5162333A
Cited
US5151413A
Cited
US5194447A
Cited
US5177203A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1998-02-06 | 1998-08-08 | 1999-02-07 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2002-02-06 | 2002-08-08 | 2003-02-07 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2006-02-06 | 2006-08-08 | 2007-02-07 | $7700.00 | Window Closed / Lapsed |